This portal was created for members of the PFSCM community to share information on supply chain efforts worldwide.
We encourage you to download documents, suggest resources and develop this space as a helpful virtual location to collaborate.


PFSCM Supply Lines Blog


This portal was created for members of the PFSCM community to share information on supply chain efforts worldwide.
We encourage you to download documents, suggest resources and develop this space as a helpful virtual location to collaborate.


GHSC Summit review

The future of global health supply chains: Key areas of focus emerge at recent summit

For the past 10 years, practitioners and experts from the global health supply chain field have gathered each year for the Global Health Supply Chain Summit to discuss the importance of supply chain performance in delivering health care and reaching countries’ health targets.

This year, the 10th annual Summit convened more than 300 delegates from public and private health organizations, government, donor groups, academic institutions, and service providers in Accra, Ghana, in November to focus on the future of global health supply chain management through enhanced engagement with the private sector, deployment of technology to improve supply chain performance, and workforce development and empowerment

Keynotes take a close look at specific supply chain challenges and solutions

Keynote addresses by two well-known global health supply chain experts were well received. Dr. Prashant Yadav, Strategy Leader–Supply Chains at Gates Foundation, looked at 10 years of progress in global health supply chains, challenges that must now be addressed, and an improvement agenda for the future, which included increased partnering with the private sector.

Dr. Iain Barton, Healthcare Strategy Executive at PFSCM member organization Imperial Logistics, spoke about the unintended consequences and hidden obstacles to medicine access, particularly the regulatory environment in Africa that can dis-incentivize market entry by reputable manufacturers. He advocated for the World Health Organization (WHO) to review and strengthen its guidelines to ensure they are supporting supply chain best practices, as governments take the lead from WHO in developing their regulations. A harmonized African regulatory environment, Iain contended, would lower prices, increase availability, and improve quality.

Other significant presentations included:

  • The future of global health supply chain management, by Francis Aboagye-Nyame, Director, Systems for Improved Access to Pharmaceuticals and Services (SIAPS)
  • Delivery and replenishment strategies used as supply chain practice—a supplier view, by Michael Heerde, Director HealthCare Programs, Bayer
  • Pharmaceutical manufacturing in Ghana: Challenges and potential for growth, by Kwasi Boateng, ASQ-CPGP, CQA Senior Manager USP-Ghana.
  • Welcoming remarks from Kingsley Aboagye-Gyedu, Deputy Minister of Health in Ghana.

Two PFSCM presentations speak to benefits of private sector engagement

PFSCM, which was a sponsor of the Summit, conducted two presentations that were well aligned with the event’s theme, particularly private sector engagement.

Stephen Kimatu, PFSCM Product Quality Assurance Manager, presented on increasing access to essential medicines through pre-qualified, quality local sources, highlighting PFSCM’s innovative initiative over the past year to establish a network of pre-qualified vendors, manufacturers, and wholesalers in Africa for compliance to WHO standards (cGMP, MQAS, or GDP). This pre-qualified network provides a number of potential benefits to clients, including reducing lead times, preventing counterfeit drugs, complying to in-country regulatory requirements for product market approval, and meeting the increased need of clients to have products sourced in country.

The audience was very responsive to Stephen’s presentation, raising discussion around cooperating with regulatory bodies in countries, harmonizing auditing tools for consistency, and sharing audit reports among peers to avoid multiple audits of the same supplier.

Ishmael Muchemenyi, PFSCM Head of Freight and Logistics, presented on last-mile delivery—reaching the finish line in the race for sustainable health impact, an area in which PFSCM has significant expertise, having managed last-mile delivery to some of the hardest-to-reach places in the world under large projects for the Global Fund and USAID. Ish led attendees through a discussion of global trends in e-commerce and last-mile delivery; triggers that bring about transformation of public health supply chains and how to entrench GDP standards; hurdles and innovative solutions for last-mile delivery; and the future of global health supply chains, including end-to-end supply chain integration and visibility.

A look at supply chain challenges on the horizon

Over the course of the three-day conference, a number of key topics emerged that reflect some of the most pressing issues for the future of global health supply chains:

  • How to help prepare governments to contract with the private sector and manage performance once work is outsourced.
  • The need for a single technology solution to provide total supply chain visibility, especially at the country level, where the biggest gap currently lies.
  • The need for stronger government policy around supply chain that promotes best practices.
  • The growing importance of GS1 standards (an integrated suite of global standards for identifying, capturing, and sharing supply chain information) and serialization of products to improve track and trace, with implementation already underway by USAID.
  • Significant access barriers facing countries graduating from donor support, due to small populations and programs; policies that require local purchasing; the high cost and time for manufacturers to register products locally; and the likelihood of ballooning drug prices, therefore limited access, if manufacturers appoint local distributors.
  • The value of an international procurement service agent (PSA) and supply chain organization to assist graduating countries.

PFSCM looks forward to continued engagement with the global health supply chain community to develop solutions to address these issues and strengthen supply chain management, never losing sight of the ultimate goal: ensuring that patients in low- and middle-income countries have continual access to the medicines they need.

About the Global Health Supply Chain Summit

The Global Health Supply Chain Summit is organized by Dr. Yehuda Bassok, Chair of the Department of Data Sciences and Operations and Professor of Data Sciences and Operations at the University of Southern California Marshall School of Business. The Summit aims to provide a forum for attendees to share challenges, solutions, and best practices; influence the health care supply chain research agenda of academics; and create a community of health care supply chain stakeholders.


The Partnership for Supply Chain Management (PFSCM) is a nonprofit organization established in 2005 by two of the leading international health consultancy organizations in the United States: JSI Research & Training Institute, Inc. (JSI), and Management Sciences for Health (MSH). PFSCM solves complex supply chain challenges by leveraging our expertise with local, regional, and international logistics stakeholders, ensuring that quality health products are accessible in low- and middle-income countries. Core partners include JSI, MSH, i+solutions, and Imperial Health Sciences (IHS).

World Aids Day focus

Word Aids Day and the HIV/AIDS epidemic: A time to reflect, but also to prepare for new challenges

In line with World Aids Day, PFSCM, reflects on the progress made and work done in the fight to end HIV/AIDS.

When PFSCM was founded in 2005, an HIV diagnosis was still a death sentence for many people in low- and middle-income countries. We have come a long way since then:

Access to antiretroviral therapy (ART) is a key reason for this progress. As of July 2017, of the 36.7 million people living with HIV globally, 20.9 million are accessing ART, up from 15.8 million in June 2015, 7.5 million in 2010, and fewer than 1 million in 2000.

This is where PFSCM plays a crucial role in the fight against AIDS, ensuring that antiretroviral medicines (ARVs) and HIV testing supplies are affordable and accessible to people in need.

PFSCM is very proud of the work it has done on behalf of the Global Fund to Fight AIDS, Tuberculosis and Malaria for its Pooled Procurement Mechanism (PPM); Gilead for PEPFAR’s DREAMS project, which has reached 1 million adolescent girls and young women; Janssen and the Elizabeth Glaser Pediatric AIDS Foundation for the New Horizons Advancing Pediatric HIV Care Collaborative; governments of countries such as the Dominican Republic and Malawi; and all our other clients and collaborators.

For the Global Fund’s PPM project, we have managed more than 8 000 shipments of ARVs and HIV rapid diagnostic tests (HRDTs) worth more than $2 billion and delivered to 64 countries since in 2009. Importantly, we have maintained a high on-time and in-full (OTIF) delivery performance on this project — currently averaging 86% for 2017.

The positive impact we’ve made on public health systems is far reaching, benefitting national health services overall and the patients they serve with vastly improved supply chains. We continue to be committed to procuring products at best price; expertly managing shipping logistics to optimize cost and delivery requirements; providing safe, secure, and sustainable storage for these drugs; and conducting last-mile delivery to some of the hardest-to-reach places in the world – all while assuring the quality of our drugs, vendors, and business processes.

Despite impressive progress made in the fight against AIDS, there is still much work to do to reach the global UNAIDS 90-90-90 targets by 2020 — which aim for 90% of people living with HIV to be diagnosed, 90% of those diagnosed to be on treatment, and 90% of those on treatment to be virally suppressed — and to ultimately achieve the global goal of ending the AIDS epidemic by 2030.

In the next year, we at PFSCM will redouble our efforts to improve efficiency and optimize performance in the supply chain, so that limitations in funding and logistical challenges do not have to mean a slowing down of treatment rates.

ISO 9001:2015 certification logos

PFSCM reaffirms commitment to quality and service excellence through new ISO 9001:2015 certification

The Partnership for Supply Chain Management (PFSCM), a leading public health supply chain solutions provider, is pleased to announce that we received ISO 9001:2015 certification on November 16, 2017.

PFSCM’s Quality Management System received its previous ISO 9001:2008 certification in 2014 and has always upheld the highest quality standards, ensuring successful annual auditing and registration by one of the world’s most reputable certification bodies for management systems, DQS Management Systems Solutions.

DQS Management Systems Solutions — which is a member of the global network of certification bodies, IQNet — audited PFSCM’s US and Netherlands offices and endorsed the recommendation to advance from 9001:2008 to 9001:2015.

PFSCM Director Richard Owens says quality management and quality assurance have always been at the core of everything PFSCM undertakes, and the new certification reaffirms the organization’s commitment to transparency, continuous improvement, and service excellence.

“We are very proud to have earned the certification to ISO 900:2015. We have always been focused on the quality and reliability of our systems, services, and processes, and having an esteemed institution such as DQS find us deserving only drives us further,” adds Owens.

What does ISO 9001:2015 mean for PFSCM and its clients?

PFSCM Senior Quality Unit Manager Michael Harrigan explains that the ISO 9001:2015 certification provides PFSCM’s current and new clients with the assurance that PFSCM’s business is conducted within a standardized framework, with processes having the required documented methodology, competent staff, and defined roles, as well as an understanding of client requirements.

This conduct involves upholding key global principles of quality management systems, some of which are summarized below:

Improving customer satisfaction: A fundamental principle of ISO 9001:2015 is to continuously improve customer satisfaction through planning and striving to meet and exceed customer expectations.

Improving process integration: ISO 9001:2015’s process approach enables an organization to easily identify areas where efficiency and cost savings can be improved. Improved process flow and integration reduces errors and inefficiencies, increasing service levels and cost savings for customers.

Upholding evidence-based decision-making: Through ISO 9001:2015, the organization commits to making decisions based on accurately analyzed data and facts. This not only ensures that the organization is able to meet and measure its goals and progress, but also gives customers the assurance that decisions are based on sound judgment.

Continuous improvement: A requirement of ISO 9001:2015 is to continuously improve the suitability, adequacy, and effectiveness of the organization’s quality management system. These improvements are based on the analysis of results and the outcomes of management reviews.

In conclusion, the ISO 9001:2015 certification provides clients with peace of mind in knowing that their expectations will be met in a transparent and compliant manner.


PFSCM strengthens public health supply chains, ensuring lifesaving commodities are available and accessible to communities in hard-to-reach places.

We help governments, nonprofit organizations, and humanitarian agencies achieve their public health goals through cost-saving procurement, efficient logistics, pharma-grade storage, last-mile delivery solutions, and real-time data tracking.

PFSCM demonstrates its commitment to customer satisfaction and service excellence by upholding our ISO 9001:2015 certified Quality Management System that underpins all our processes, systems, and services.

PFSCM has been a Procurement Services Agent for The Global Fund to Fight AIDS, Tuberculosis and Malaria’s Pooled Procurement Mechanism since 2009.

Global Health Supply Chain logo

This year the Global Supply Chain Summit will be taking place in Ghana from 15 to 17 November.

The theme of this year’s conference is Linking to the future of Global Health Supply Chain Management: Enhancing the role of the private sector, technology enablement, and workforce development and empowerment.

PFSCM will be presenting on two very relevant and pressing topics:

Reaching the last mile: Improving supply chain performance through private-sector investment

– by PFSCM Head of Logistics, Ishmael Muchemenyi

Underperformance and the impact on last-mile delivery remains the biggest challenge faced by public health supply chains in developing countries. Aging and limited supply chain infrastructures are coming under increasing pressure to meet new demands, such as the need for transparent data, measurable last-mile results, and performance tracking. Leveraging the existing commercial services and capacity of private-sector entities will enable these supply chains to become sustainable, high-performing mechanisms that can adopt new technologies to overcome last-mile challenges. At the GHSC Summit, PFSCM will delve into a proven approach of investing in private-sector entities to advance our quality standards through training, capacity building, and infrastructure development.

Topics to be explored include:

  • Achieving public health drug deliveries by contracting with and managing local logistics service providers.
  • Improving the performance of local private-sector actors to support public health requirements.
  • Achieving private-sector performance levels in public health supply chains.

Increasing access to essential medicines through pre-qualified, quality local sources

– by PFSCM Product Quality Assurance Unit Manager, Stephen Kimatu

In many low-income countries, especially in Africa, the supply of quality-assured essential medicines tends to be inconsistent and unreliable. Poorly resourced public-sector supply chains, pervasive risk of falsified or substandard pharmaceuticals, a lack of World Health Organization (WHO)-prequalified local manufacturing sites, and scarcity of products approved by a stringent regulatory authority (SRA) are all factors that hamper the sustainable development of supply chains.

Recognizing this problem, PFSCM launched an innovative audit and prequalification program to assess a pharmaceutical wholesaler, distributor, or manufacturer’s level of compliance with leading compliance and quality standards, such as those set out by the WHO. Once prequalified, further investments can be made to assist vendors in advancing quality and compliance.

Using this approach, PFSCM has developed a network of prequalified local sources in Africa. This network brings essential medicines closer to patients and aids in developing supply chains and directly supporting donor programs and local governments.

Topics to be explored include:

  • PFSCM’s product QA approach, experience, and coverage.
  • How developing the capacity of local private sector pharmaceutical wholesalers increases drug availability in low- and middle-income countries (LMICs).
  • Specific examples highlighting the health access impacts as a result of private sector development and support.

For more details about the conference, visit the GHSCS website.

Click here to get in touch with PFSCM.





Clinical microbiology conference logo

PFSCM partner Imperial Logistics has established a new working group on supply chain control towers.

“The working group aims to ensure a shared understanding of supply chain control towers and to explore potential business opportunities, specifically where current client relationships can be enhanced,” says Imperial Logistics chief strategy officer Cobus Rossouw.

In addition, the working group will articulate and document an implementation roadmap for Imperial Logistics’ supply chain control towers.

Click here to read more.





Clinical microbiology conference logo

David Jamieson, PFSCM Global Partnerships Adviser, presented a keynote to the Clinical Microbiology conference in Rome, Italy, this week on the supply chain challenges and achievements in meeting the UNAIDS 90-90-90 targets to contain the HIV epidemic.

Based on the paper David published in 2015 in the Journal of the International AIDS Society (JIAS), he updated the meeting on the achievements so far as demonstrated by recent UNAIDS estimates of numbers infected, on treatment, and achieving viral suppression.

Using the theme of closing in on the targets, he showed how in rural East Africa, UNAIDS estimates that 90% know their status, and most of those are on treatment with encouraging viral suppression results (see image of presentation slide below). David also showed how five African countries are closing in on epidemic control, which is when the number of new infections drops below the number of deaths from AIDS-related illness.

These results demonstrate that, as shown in David’s paper, the supply chain has adapted to the increases demanded to reach the 90-90-90 targets, but more still needs to be done.

Challenges include the number of new infections, for which the rate is not slowing down enough; marginalized populations, which remain at great risk; and the rate of new infection in Eastern Europe and central Asia, which is accelerating alarmingly.

For the supply chain, chain David emphasized the continued need to engage the private sector; the need to be flexible and adaptive for new testing approaches, such as self-testing; and the need to bring exciting new drugs into use faster than ever before.

Questions from the conference were mainly around the continued challenges in getting people, especially men, to come forward for testing. If we do not achieve the first 90, with 90% of people with HIV knowing their status, then the second and third 90s cannot be achieved. Concern was also expressed about the risk of viral resistance as some of the older drugs become less effective over time.

David ended his presentation on a positive note, saying that well-managed supply chains can support 90-90-90, but we have to continue to adapt and respond as needs change and exciting new drugs become available, and be resilient in ensuring high performance, as millions rely on the drugs and diagnostics that we must supply on time and to the best value over the coming years.




VMMC guide cover

We have known for years that if babies born with HIV do not receive treatment, more than 50 percent will die before their second birthday, but we also know that when treated, they can grow into healthy adults. Until very recently, a big challenge has been reaching mothers and their new babies soon enough, testing baby, and getting the results back to mom. Reliable diagnosis could only be completed in larger laboratories, meaning blood samples had to be transported to the lab, kept fresh for testing, and then the results returned — by which time, mother and baby were probably back in their village and might never get the result.

PFSCM has always been firmly committed to improving the care, detection, and treatment of the youngest patients. Drawing on our expertise in managing global supply chains and optimizing laboratory networks, our contribution will be to ensure that the supply chain doesn’t let these patients down; that smart network design places these new instruments where they will make the most difference; and that results get back to mom and her health caregivers at the earliest opportunity.

Read more at our PFSCM Supply Lines blog.

VMMC guide cover

The Under the auspices and funding of SCMS, has developed a new comprehensive toolkit that provides guidance on health care waste management (HCWM) and environmental hygiene best practices for VMMC services. The toolkit is available for download on USAID’s AIDSFree website.

The toolkit contains two components — program guidance and site guidance — each of which is based on VMMC program experience, WHO guidance, and USAID environmental protection/compliance regulations.

Program guidance

The resources in the toolkit’s program guidance component provide VMMC implementing partners with guiding principles for the design, implementation, and monitoring of VMMC environmental health programs. Resources include:

  • A program management guide on safer HCWM practices in VMMC programs
  • Assessment tools
  • Incident management tools
  • Audit tools
  • Disposal guidance for unusable medical products
  • Disposal guidance for unusable pharmaceutical products

Site guidance

In the site guidance component of the toolkit, the resources provide health service providers with specific guidance and tools to teach and reinforce environmental health management. Resources include:

  • A site management guide on environmental health management in VMMC programs
  • Training materials, including a staff pocket guide with a key ring
  • Posters
  • Assessment tools
  • Incident management tools
  • Monitoring tools
  • Disposal guidance for unusable medical products

Through the support of PEPFAR, the President’s Malaria Initiative (PMI), and USAID, PFSCM and the USAID | DELIVER PROJECT contributed to strengthening Zambia’s public health supply chain for HIV/AIDS medicines, malaria medicines, essential medicines, and family planning products. The projects worked to build the capacity of the Government of Zambia (GRZ) to ensure the availability and security of vital health commodities at service level sites by:

  • Strengthening logistics systems to avail critical data for informed supply chain decision making;
  • Increasing ownership to conduct coordinated, transparent quantification, procurement planning, and supply monitoring;
  • Providing cost effective,reliable procurement services;
  • Reinforcing infrastructure for warehousing, distribution, and testing; and
  • Improving strategic management and planning for increased commodity security.

Check out this video to learn more about the supply chain challenges faced when the two projects began and the achievements brought about through collaboration with the Ministry of Health, Medical Stores Limited (MSL), and other partners. The video also looks ahead at the future of the supply chain in Zambia, with recipient, implementer, and donor testimony.

IATT paediatric updated ARV formulary and limited-use list: 2016 update

The 2016 update to the IATT Paediatric ARV Formulary and Limited-Use List has now been officially endorsed by both WHO and UNICEF and is available online.

The first IATT optimal paediatric ARV formulary was created in 2011 by the Child Survival Working Group and the Supply Chain Management Working Group of the Interagency Task Team (IATT) on the Prevention and Treatment of HIV Infection in Pregnant Women, Mothers, and Children. Since then, the group has convened in conjunction with the ARV Procurement Working Group (APWG) every six months, and following any updates from the WHO Consolidated ARV Guidelines, to update the existing optimal paediatric ARV formulary. This edition reflects the 2016 WHO Consolidated Guidelines and takes account of changes in the markets.

The list continues to serve as guidance for national programs, procurement agencies, funders, and manufacturers to select products that closely align to the criteria describing optimal paediatric dosage forms.


A new paper from the Global Fund and UNITAID describes how the challenging market for paediatric anti-retroviral medicines has been transformed.

The Paediatric ARV Procurement Working Group (PAPWG) was established in 2011 to address procurement and access challenges in the small and highly fragile paediatric ARV market. The Working Group was established as a global collaboration and coordination, including major financiers and procurers of ARVs, as well as technical bodies, through procurement promoting optimal products and regimens. Bringing these partners together enabled greater visibility into this fragile market than any one partner could achieve alone. The PAPWG’s leadership and successful management of the paediatric ARV market has ensured an uninterrupted supply and treatment for children living with HIV. PFSCM and SCMS were founding members of the PAPWG.

The paper and lessons learned can be found here.

The approach taken by the Working Group is now being applied to other commodities and health interventions with similar market conditions. In early 2016, the PAPWG expanded its mandate to include specialist adult ARVs facing similar market challenges, and to support the scale-up of new optimal regimens and formulations.

warehouse workers

The UNAIDS “90-90-90” strategy calls for 90% of HIV-infected individuals to be diagnosed by 2020, 90% of whom will be on ARTs and 90% of whom will achieve sustained virologic suppression. Reaching these targets by 2020 will reduce the HIV epidemic to a low-level endemic disease by 2030. From a supply chain perspective, each of the “90’s” has possible complications and roadblocks towards realizing the promise envisioned by 90-90-90.

Read a “real world analysis” of these proposed strategies and policies in our article “The 90 90 90 strategy to end the HIV Pandemic by 2030: Can the supply chain handle it?” just published in the Journal of the International AIDS Society.

mother and child

The new, scored, fixed-dose combination (FDC) tablet containing 120 mg of Abacavir (ABC) and 60 mg of Lamivudine (3TC) is available for procurement through Mylan.

This formulation can significantly decrease pill burden in children (by at least 50% compared to existing formulations of ABC), particularly when used as a once-daily regimen. The reduced pill burden may improve patient adherence and simplify the supply chain at no additional cost to national HIV programs. Furthermore, this formulation may prevent sub-optimal dosing that occurs when adult formulation tablets are cut for use by children.

For further background and a dosing chart for quantification of ABC/3TC (120/60 mg) requirements by weight band, please see the information briefs available in English, French, and Spanish.

ABC/3TC (120/60 mg) Tablet Informational Brief

Note d’information sur les comprimés d’ABC/3TC (120/60 mg)

Nota informativa sobre la pastilla ABC/3TC (120/60 mg)

Storage facilities are critical in ensuring that people can receive the life-saving medicines they need for survival. Without proper storage, drugs can lose potency, become damaged or even be stolen. Earlier this year, SCMS began the deployment of 115 storage-in-a-box (SiB) units in Malawi, funded by USAID and the Department for International Development (DFID).

To learn more, check out the MBC News video, taken during the launch of the first SiB at the Chitedze Health Centre in Lilongwe. It features interviews with Ministry of Health Principal Secretary Mc Phail Magwira, USAID Mission Director Doug Arbuckle, and DFID head in Malawi, Philip Smith, on this critical effort.

mowafy picture

USAID published a great story about SCMS in its USAID Impact Blog titled, “Delivering Life-Saving HIV/AIDS Drugs Around the World” by Sherif Mowafy. It highlights the importance of supply chains in public health and cites some of SCMS’s many successes and impacts. This story further promotes our SCMS 10 Year Review, “Ten Years of Supporting PEPFAR through Stronger Public Health Supply Chains.”

pepfar hands holding ribbon

SCMS is proud to release its report, “10 Years of Supporting PEPFAR through Stronger Public Health Supply Chains: A Report on SCMS Contributions to PEPFAR Results.” As SCMS marks a decade of operating the largest public health supply chain in the world on behalf of the US government, the project looks back at how it helped to move the global community closer to reaching our collective goal: achieving an AIDS-free generation.

At the International AIDS Conference in July in Durban, South Africa, PFSCM conducted a satellite panel discussion with the theme of “Meeting the Supply Chain Challenge of 90-90-90.” The 90-90-90 targets have a number of ramifications on the various elements of the supply chain.

Five panelists representing UNAIDS, which established the 90-90-90 goals; WHO, which develops related policy and guidance; Mylan, an ARV manufacturer; Alere, a diagnostics manufacturer; and Imperial Health Sciences, a health logistics firm and PFSCM partner, engaged in thought-provoking discussion to unpack the challenges facing each 90.

PFSCM’s David Jamieson introduced the panel discussion and framed the discussion around innovations needed to achieve the 90-90-90 goals. With PFSCM’s Gordon Comstock moderating the panel, Peter Ghys of UNAIDS and Daniel Low-Beer of WHO spoke about the modeling that led to 90-90-90 and the innovations needed to treat all. Arvind Kanda of Mylan, Willem Pretorius of Alere, and Iain Barton of Imperial Health Sciences discussed the specific pharmaceutical, diagnostics, and logistics innovations needed to achieve 90-90-90.

PFSCM Supply Lines Blog

PFSCM Supply Lines is a platform to share our health supply chain knowledge and the latest public health news with our stakeholders and interested parties.